{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T12:10:21Z","timestamp":1685794221476},"reference-count":92,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.earlhumdev.2010.08.010","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T08:14:51Z","timestamp":1284970491000},"page":"695-701","source":"Crossref","is-referenced-by-count":10,"title":["Challenges in immunisation against bacterial infection in children"],"prefix":"10.1016","volume":"86","author":[{"given":"Johannes","family":"Tr\u00fcck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0005","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.vaccine.2006.09.008","article-title":"The preventable burden of pneumococcal disease in the developing world","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0015","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0020","first-page":"445","article-title":"WHO position paper on Haemophilus influenzae type b conjugate vaccines","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","article-title":"Burden of disease caused by Haemophilus influenzae type b in children younger than 5years: global estimates","volume":"374","author":"Watt","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0030","first-page":"331","article-title":"Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines","volume":"77","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0035","unstructured":"Health Protection Agency \u2014 Hib laboratory reports to CDSC: England and Wales 1990\u20132003. [accessed April 2010]; available from: http:\/\/www.hpa.org.uk."},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0045","series-title":"Invasive pneumococcal disease (IPD) in England & Wales after 7-valent conjugate vaccine (PCV7); potential impact of 10 and 13-valent vaccines: Health Protection Agency","author":"Kaye","year":"2009"},{"issue":"Suppl 3","key":"10.1016\/j.earlhumdev.2010.08.010_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2009.02724.x","article-title":"The antimicrobial resistance profile of Streptococcus pneumoniae","volume":"15","author":"Reinert","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"Dagan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006454-200202000-00011","article-title":"Six year multicenter surveillance of invasive pneumococcal infections in children","volume":"21","author":"Kaplan","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0065","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/340400","article-title":"Resistance among Streptococcus pneumoniae: implications for drug selection","volume":"34","author":"Appelbaum","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl S2","key":"10.1016\/j.earlhumdev.2010.08.010_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkf506","article-title":"Dynamics of nasopharyngeal colonization by potential respiratory pathogens","volume":"50","author":"Garcia-Rodriguez","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.inf.0000151030.10159.b1","article-title":"Acquisition of Streptococcus pneumoniae and nonspecific morbidity in infants and their families: a cohort study","volume":"24","author":"Sleeman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1542\/peds.112.5.1095","article-title":"Streptococcus pneumoniae infections in the neonate","volume":"112","author":"Hoffman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0085","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/586716","article-title":"School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom","volume":"197","author":"Oh","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3476(05)83529-2","article-title":"Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine","volume":"122","author":"Murphy","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.269.2.246","article-title":"Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination","volume":"269","author":"Murphy","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","article-title":"The epidemiology of meningococcal disease and the impact of vaccines","volume":"9","author":"Khatami","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0110","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.vaccine.2008.05.073","article-title":"Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae","volume":"26","author":"Trotter","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0130","first-page":"CD001480","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","author":"Jansen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated post-licensure surveillance of meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlate of protection and modelling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0140","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0145","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0150","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0155","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0160","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1001\/jama.294.23.3019","article-title":"Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens","volume":"294","author":"Kelly","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0165","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.88.5.379","article-title":"Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure","volume":"88","author":"McVernon","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0175","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0185","doi-asserted-by":"crossref","unstructured":"Khatami A., Snape M.D., John T. et al. Persistence of immunity following a booster dose of Hib-MenC-TT glycoconjugate vaccine: follow-up of a randomised controlled trial Pediatr Infect Dis in press;30(3), doi:10.1097\/INF.0b013e3181f728fd.","DOI":"10.1097\/INF.0b013e3181f728fd"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0190","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.284.18.2334","article-title":"Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom","volume":"284","author":"Heath","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0195","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/INF.0b013e3181d99345","article-title":"Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial","volume":"29","author":"Givon-Lavi","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4161\/hv.4.4.5437","article-title":"Sustaining immunity after immunization against encapsulated bacteria","volume":"4","author":"Blanchard-Rohner","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0205","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/eji.1830131008","article-title":"One out of five peripheral blood B lymphocytes is activated to high-rate Ig production by human alloreactive T cell clones","volume":"13","author":"Lanzavecchia","year":"1983","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0215","doi-asserted-by":"crossref","first-page":"13263","DOI":"10.1073\/pnas.230417497","article-title":"Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs","volume":"97","author":"Ochsenbein","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0230","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/600292","article-title":"Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom","volume":"49","author":"Ladhani","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2009.10.008","article-title":"Invasive pneumococcal infections among vaccinated children in the United States","volume":"156","author":"Park","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0245","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom","volume":"29","author":"Goldblatt","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0260","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/adc.67.4.475","article-title":"Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule","volume":"67","author":"Booy","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0265","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1001\/jama.266.14.1960","article-title":"Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group","volume":"266","author":"Holmes","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/524668","article-title":"Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody","volume":"46","author":"Lee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0280","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/bmj.326.7400.1158","article-title":"Haemophilus influenzae type b vaccine\u2013booster campaign","volume":"326","author":"Heath","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0285","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0290","series-title":"Immunisation against infectious disease \u201cThe green book\u201d","first-page":"17","year":"2006"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0295","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38906.704549.7C","article-title":"Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial","volume":"333","author":"Diggle","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0300","series-title":"Immunisation againts infectious disease \u201cThe green book\u201d","first-page":"25","year":"2006"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0305","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.vaccine.2008.12.060","article-title":"Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure","volume":"27","author":"O'Brien","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.inf.0000109221.50972.53","article-title":"Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide\u2013diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants","volume":"23","author":"Dagan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0315","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.vaccine.2005.12.025","article-title":"Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens","volume":"24","author":"Mahon","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0320","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0325","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1473-3099(06)70584-9","article-title":"No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales","volume":"6","author":"Trotter","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0330","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0335","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O'Brien","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0345","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0350","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/597045","article-title":"Rethinking replacement and resistance","volume":"199","author":"Moore","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0355","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/INF.0b013e3181c391fb","article-title":"The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation","volume":"29","author":"Black","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.112.1.193","article-title":"Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases","volume":"112","author":"Saari","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0365","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1542\/peds.2008-0231","article-title":"Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population","volume":"123","author":"Batra","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0370","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/adc.2005.086306","article-title":"Immunisation of premature infants","volume":"91","author":"Bonhoeffer","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0375","series-title":"Immunisation against infectious disease \u201cThe green book\u201d","first-page":"50","year":"2006"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0380","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006454-200203000-00003","article-title":"Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-10-12","article-title":"Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants","volume":"10","author":"Ruckinger","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0390","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.inf.0000187027.45918.6a","article-title":"Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants","volume":"24","author":"Collins","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0395","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/324666","article-title":"Immune response of premature infants to meningococcal serogroup C and combined diphtheria\u2013tetanus toxoids\u2013acellular pertussis\u2013Haemophilus influenzae type b conjugate vaccines","volume":"184","author":"Slack","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0400","unstructured":"Immunisation against infectious disease \u201cThe green book\u201d. In: Salisbury, D., Ramsay, M., Noakes, K., editors. Third edition ed. London; 2006. p. 134\u20135; 246\u20137; 307."},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0405","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.vaccine.2004.09.029","article-title":"Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11months post-natally to pre- and full-term infants","volume":"23","author":"Esposito","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0410","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2006.07.036","article-title":"Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0415","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/INF.0b013e3181d264a6","article-title":"Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants","volume":"29","author":"D'Angio","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0420","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.vaccine.2007.04.018","article-title":"Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11months post-natally to pre- and full-term infants","volume":"25","author":"Esposito","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0425","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0022-3476(05)80862-5","article-title":"Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants","volume":"123","author":"Washburn","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","article-title":"Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants","volume":"121","author":"Granoff","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0435","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1542\/peds.96.2.216","article-title":"Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine","volume":"96","author":"Munoz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0440","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1542\/peds.109.3.498","article-title":"Seven-year follow-up of vaccine response in extremely premature infants","volume":"109","author":"Kirmani","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0445","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.96.1.18","article-title":"Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations","volume":"96","author":"D'Angio","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0450","doi-asserted-by":"crossref","first-page":"F69","DOI":"10.1136\/fn.80.1.F69","article-title":"Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease","volume":"80","author":"Robinson","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0455","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00006454-199606000-00010","article-title":"Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants","volume":"15","author":"Kristensen","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.earlhumdev.2010.08.010_bb0460","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/adc.88.3.206","article-title":"Hib vaccination in infants born prematurely","volume":"88","author":"Heath","year":"2003","journal-title":"Arch Dis Child"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378210002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378210002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T11:38:24Z","timestamp":1685792304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378210002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":92,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0378378210002124"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.08.010","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}